Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
BackgroundTo investigate the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on renal outcomes in patients with type 2 diabetes.MethodsMEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched to identify randomized controlled trials (RCTs) of DPP-4 inhibitors from i...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Endocrine Society
2019-03-01
|
Series: | Endocrinology and Metabolism |
Subjects: | |
Online Access: | https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-34-80.pdf |